Biostage, Inc.
OTC: BSTG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Junli He
- Employees
- 7
- Headquarters
- Holliston, United States
- IPO year
- 2013
- Market cap
- $57.8M
- Website
- https://biostage.com
Loading BSTG…
Loading profile data…Frequently asked questions about BSTG
What does Biostage, Inc. (BSTG) do?
Biostage, Inc. is a biotechnology enterprise dedicated to developing medical products aimed at curing patients suffering from cancers, injuries, and congenital defects within the gastrointestinal system and respiratory pathways. A primary focus for the company is the advancement of its Biostage Esophageal Implant, specifically designed to addres...
Where does BSTG trade?
Biostage, Inc. (BSTG) trades on the Other OTC.
What sector is BSTG in?
Biostage, Inc. (BSTG) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biostage, Inc.?
Junli He is the chief executive officer of Biostage, Inc. (BSTG).
Where is Biostage, Inc. headquartered?
Biostage, Inc. is headquartered in United States.
Does BSTG pay a dividend?
Biostage, Inc. (BSTG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BSTG go public?
Biostage, Inc. (BSTG) completed its initial public offering in 2013.